This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Amy L Funk - Innovator in Targeted Degradation Technologies.
Introduction
Amy L Funk is an accomplished inventor based in Frederick, MD (US). She has made significant contributions to the field of targeted degradation technologies. Her innovative work focuses on developing compounds that can inhibit the activity of specific proteins, which may have implications for treating various diseases.
Latest Patent Applications
Amy L Funk has filed a patent application titled "LZK-TARGETING DEGRADERS AND METHODS OF USE." This application discloses leucine zipper-bearing kinase (LZK) targeted degraders. The compounds have a general formula Q-L-Z, where Q is an LZK binding moiety, L is a linker, and Z is an E3-ligase binding moiety. These compounds are designed to inhibit LZK activity and/or degrade LZK. They may be utilized in treating diseases or conditions characterized at least in part by LZK overexpression.
Conclusion
Amy L Funk's innovative work in targeted degradation technologies showcases her commitment to advancing medical science. Her contributions may pave the way for new therapeutic strategies in the future.